GALERA THERAPEUTICS INC (GRTX) Forecast, Price Target & Analyst Ratings

NASDAQ:GRTX • US36338D1081

Current stock price

0.145 USD
-0.07 (-32.59%)
At close:
0.1379 USD
-0.01 (-4.9%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GALERA THERAPEUTICS INC (GRTX).

Forecast Snapshot

Consensus Price Target

Price Target
$0.38
+ 163.79% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 12, 2024
Period
Q2 / 2024
EPS Estimate
$0.26
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
45.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$0.38
Upside
+ 163.79%
From current price of $0.15 to mean target of $0.38, Based on 7 analyst forecasts
Low
$0.25
Median
$0.38
High
$0.53

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for GRTX. The average price target is 0.38 USD. This implies a price increase of 163.79% is expected in the next year compared to the current price of 0.145.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GRTX Current Analyst RatingGRTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

GRTX Historical Analyst RatingsGRTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
45.71%
GRTX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about GRTX.
In the previous month the buy percentage consensus was at a similar level.
GRTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-29CitigroupMaintains Neutral -> Neutral
2023-08-16HC Wainwright & Co.Downgrade Buy -> Neutral
2023-08-10Piper SandlerDowngrade Overweight -> Neutral
2023-07-17HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-22HC Wainwright & Co.Maintains Buy
2023-02-21Piper SandlerInitiate Overweight
2023-02-16B of A SecuritiesUpgrade Underperform -> Buy
2023-02-16HC Wainwright & Co.Reiterate Buy
2022-05-27B of A SecuritiesDowngrade Neutral -> Underperform
2021-12-20CitigroupMaintains Buy
2021-12-15BTIGUpgrade Neutral -> Buy
2021-12-15HC Wainwright & Co.Upgrade Neutral -> Buy
2021-10-20HC Wainwright & Co.Downgrade Buy -> Neutral
2021-10-19BTIGDowngrade Buy -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 12, 2024
Period
Q2 / 2024
EPS Estimate
$0.26
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
154.93%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

GRTX is expected to report earnings on 8/12/2024. The consensus EPS estimate for the next earnings is 0.26 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
GRTX revenue by date.GRTX revenue by date.
N/AN/A
398.12%
EBITDA
YoY % growth
GRTX ebitda by date.GRTX ebitda by date.
-24.01M-24.13M
-0.50%		-50.42M
-108.95%		-70.18M
-39.19%		-72.59M
-3.43%		-51.12M
29.58%		-46.692M
8.66%		N/A
112.83%		N/A
-845.51%
EBIT
YoY % growth
GRTX ebit by date.GRTX ebit by date.
-24.09M-24.26M
-0.71%		-50.69M
-108.94%		-70.55M
-39.18%		-73.37M
-4.00%		-51.23M
30.18%		-46.951M
8.35%		N/A
66.13%		N/A
-181.43%
Operating Margin
GRTX operating margin by date.GRTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
GRTX eps by date.GRTX eps by date.
N/AN/AN/A-2.98
-29.98%		-3.13
-5.03%		-2.30
26.52%		N/A
19.46%		N/A
31.72%		N/A
37.02%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		0.26
154.93%		-0.30
-5.64%		-0.31
5.51%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-9.69M
42.36%		-8.67M
21.82%		-9.18M
-77.36%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GRTX Yearly Revenue VS EstimatesGRTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 20M 40M 60M 80M 100M
GRTX Yearly EPS VS EstimatesGRTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

GALERA THERAPEUTICS INC / GRTX Forecast FAQ

What is the average price target for GALERA THERAPEUTICS INC (GRTX) stock?

7 analysts have analysed GRTX and the average price target is 0.38 USD. This implies a price increase of 163.79% is expected in the next year compared to the current price of 0.145.

What is the next earnings date for GRTX stock?

GALERA THERAPEUTICS INC (GRTX) will report earnings on 2024-08-12, before the market open.

What are the consensus estimates for GRTX stock next earnings?

The consensus EPS estimate for the next earnings of GALERA THERAPEUTICS INC (GRTX) is 0.26 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for GALERA THERAPEUTICS INC (GRTX) stock?

The consensus rating for GALERA THERAPEUTICS INC (GRTX) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.